A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Completed · Phase 3

Conditions studied: Atopic Dermatitis

In brief

This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD. The study will also evaluate the long-term efficacy of difamilast ointment 1%, including durability of response.

Key facts

Study ID
NCT05571943
Run by
Acrotech Biopharma Inc.
People needed
542
Starts
2022-09-15
Expected to finish
2024-07-31
Last updated by the study team
2024-08-09

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.